NCT00896480 2021-04-08Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous MelanomaGlaxoSmithKlinePhase 2 Completed24 enrolled 26 charts